Analysis of the landmark 2024 JAMA study on statins and dementia risk. Learn about the 24% risk reduction, best statin types, duration needed, and important limitations.
tskkc.com
Enroll Now
Analysis of the landmark 2024 JAMA study on statins and dementia risk. Learn about the 24% risk reduction, best statin types, duration needed, and important limitations.